Reference health
Characterization of GABAergic Marker Expression in the Chronic Unpredictable Stress Model of Depression
97/97 checkable references clean · checked 2026-07-23
Every reference with a DOI in the deposited reference list resolved to a known work in Crossref or DataCite at the dated check, and none carried a retraction, withdrawal, or removal notice.
3 without a DOI — not checked. A reference deposited without a DOI is never matched by title or guessed at; it stays outside the checked set, and this line discloses that.
The 97 checked references that resolve
resolves10.1001/archpsyc.62.6.593
Lifetime Prevalence and Age-of-Onset Distributions of DSM-IV Disorders in the National Comorbidity Survey Replication
resolves10.1176/appi.ajp.163.1.28
Evaluation of Outcomes With Citalopram for Depression Using Measurement-Based Care in STAR*D: Implications for Clinical Practice
resolves10.1016/0006-3223(92)90039-3
Low plasma γ-aminobutyric acid levels in male patients with depression
resolves10.2174/187152707780363294
GABAergic Contributions to the Pathophysiology of Depression and the Mechanism of Antidepressant Action
resolves10.1001/archpsyc.64.2.193
Reduced Prefrontal Glutamate/Glutamine and γ-Aminobutyric Acid Levels in Major Depression Determined Using Proton Magnetic Resonance Spectroscopy
resolves10.1001/archpsyc.56.11.1043
Reduced Cortical γ-Aminobutyric Acid Levels in Depressed Patients Determined by Proton Magnetic Resonance Spectroscopy
resolves10.1001/archpsyc.61.7.705
Subtype-Specific Alterations of γ-Aminobutyric Acid and Glutamatein Patients With Major Depression
resolves10.1001/archgenpsychiatry.2011.131
Anterior Cingulate Cortexγ-Aminobutyric Acid in Depressed Adolescents
resolves10.1016/j.biopsych.2008.10.025
Amino Acid Neurotransmitters Assessed by Proton Magnetic Resonance Spectroscopy: Relationship to Treatment Resistance in Major Depressive Disorder
resolves10.1038/sj.npp.1301234
GABAergic Neurons Immunoreactive for Calcium Binding Proteins are Reduced in the Prefrontal Cortex in Major Depression
resolves10.1017/S1461145709990587
Reduced level of glutamic acid decarboxylase-67 kDa in the prefrontal cortex in major depression
resolves10.1016/j.neuron.2016.06.033
GABAergic Interneurons in the Neocortex: From Cellular Properties to Circuits
resolves10.1002/dneu.20853
Three groups of interneurons account for nearly 100% of neocortical GABAergic neurons
resolves10.1176/appi.ajp.2012.12020248
Brain-Derived Neurotrophic Factor Signaling and Subgenual Anterior Cingulate Cortex Dysfunction in Major Depressive Disorder
resolves10.1017/S1461145710001616
GABA-related transcripts in the dorsolateral prefrontal cortex in mood disorders
resolves10.1016/j.jad.2008.04.021
Suicide and depression in the quantitative analysis of glutamic acid decarboxylase-Immunoreactive neuropil
resolves10.1016/j.biopsych.2009.10.027
Reduced Density of Calbindin Immunoreactive GABAergic Neurons in the Occipital Cortex in Major Depression: Relevance to Neuroimaging Studies
resolves10.1016/j.euroneuro.2011.09.001
Neuropathological abnormalities of astrocytes, GABAergic neurons, and pyramidal neurons in the dorsolateral prefrontal cortices of patients with major depressive disorder
resolves10.1016/S0006-3223(02)01360-4
Selective deficits in prefrontal cortical GABAergic neurons in schizophrenia defined by the presence of calcium-binding proteins
resolves10.1016/S0006-3223(01)01243-4
The density and spatial distribution of gabaergic neurons, labelled using calcium binding proteins, in the anterior cingulate cortex in major depressive disorder, bipolar disorder, and schizophrenia
resolves10.1007/s00213-010-1835-6
Sustained stress-induced changes in mice as a model for chronic depression
resolves10.1016/S0006-8993(01)02641-5
Differential regulation of forebrain glutamic acid decarboxylase mRNA expression by aging and stress
resolves10.1016/j.neuroscience.2012.11.037
Altered GABAergic and glutamatergic activity within the rat hippocampus and amygdala in rats subjected to repeated corticosterone administration but not restraint stress
resolves10.1007/s00429-012-0479-1
Chronic stress alters inhibitory networks in the medial prefrontal cortex of adult mice
resolves10.1016/j.neubiorev.2012.07.001
Neurobiology of chronic mild stress: Parallels to major depression
resolves10.1016/S1734-1140(10)70383-2
Alterations in hippocampal calcium-binding neurons induced by stress models of depression: a preliminary assessment
resolves10.1016/S1734-1140(11)70718-6
Different pattern of changes in calcium binding proteins immunoreactivity in the medial prefrontal cortex of rats exposed to stress models of depression
resolves10.1038/sj.npp.1300581
Chronic Stress Decreases the Number of Parvalbumin-Immunoreactive Interneurons in the Hippocampus: Prevention by Treatment with a Substance P Receptor (NK1) Antagonist
resolves10.1016/j.cobeha.2016.09.012
Prefrontal cortex GABAergic deficits and circuit dysfunction in the pathophysiology and treatment of chronic stress and depression
resolves10.1038/mp.2008.106
Glial pathology in an animal model of depression: reversal of stress-induced cellular, metabolic and behavioral deficits by the glutamate-modulating drug riluzole
resolves10.1016/j.biopsych.2007.02.006
Chronic Unpredictable Stress Decreases Cell Proliferation in the Cerebral Cortex of the Adult Rat
resolves10.1016/S0006-3223(00)01088-X
Glucocorticoid receptors in major depression: relevance to pathophysiology and treatment
resolves10.1016/j.brainres.2010.08.078
Pharmacological characterization of repeated corticosterone injection-induced depression model in rats
resolves10.1016/j.biopsych.2010.12.015
Glutamate N-methyl-D-aspartate Receptor Antagonists Rapidly Reverse Behavioral and Synaptic Deficits Caused by Chronic Stress Exposure
resolves10.1016/j.biopsych.2011.06.028
Gene Profiling Reveals a Role for Stress Hormones in the Molecular and Behavioral Response to Food Restriction
resolves10.1016/j.biopsych.2009.09.025
Evidence of Cortical Inhibitory Deficits in Major Depressive Disorder
resolves10.1016/j.clinph.2013.01.014
A meta-analysis of cortical inhibition and excitability using transcranial magnetic stimulation in psychiatric disorders
resolves10.1503/jpn.150223
Elevated prefrontal cortex GABA in patients with major depressive disorder after TMS treatment measured with proton magnetic resonance spectroscopy
resolves10.1016/j.comppsych.2014.08.007
TMS over the left dorsolateral prefrontal cortex increases GABA concentration in the ventromedial prefrontal cortex in major depression
resolves10.1016/j.schres.2004.02.017
GABAergic dysfunction in schizophrenia and mood disorders as reflected by decreased levels of glutamic acid decarboxylase 65 and 67 kDa and Reelin proteins in cerebellum
resolves10.1016/j.jpsychires.2011.10.011
Expression of PSA-NCAM and synaptic proteins in the amygdala of psychiatric disorder patients
resolves10.1038/nm.2886
Decreased expression of synapse-related genes and loss of synapses in major depressive disorder
resolves10.1007/BF00966084
The structural and functional heterogeneity of glutamic acid decarboxylase: A review
resolves10.1006/bbrc.1996.1898
Mice Lacking the 65 kDa Isoform of Glutamic Acid Decarboxylase (GAD65) Maintain Normal Levels of GAD67 and GABA in Their Brains but Are Susceptible to Seizures
resolves10.1073/pnas.94.12.6496
Cleft palate and decreased brain γ-aminobutyric acid in mice lacking the 67-kDa isoform of glutamic acid decarboxylase
resolves10.1016/j.biopsych.2009.02.027
Increased Vulnerability to Depressive-Like Behavior of Mice with Decreased Expression of VGLUT1
resolves10.1016/j.bbr.2007.03.018
Extracellular levels of serotonin and GABA in the hippocampus after chronic mild stress in rats. A microdialysis study in an animal model of depression
resolves10.1016/j.jad.2012.05.022
The relevance of oxidative stress status in first episode and recurrent depression
resolves10.1002/hup.829
Major depressive disorder is accompanied with oxidative stress: short‐term antidepressant treatment does not alter oxidative–antioxidative systems
resolves10.1016/j.jpsychires.2012.06.008
Oxidative stress and glutathione response in tissue cultures from persons with major depression
resolves10.1016/j.neulet.2014.03.056
In vivo 1H MRS study of potential associations between glutathione, oxidative stress and anhedonia in major depressive disorder
resolves10.1016/j.physbeh.2016.03.017
Chronic unpredictable mild stress generates oxidative stress and systemic inflammation in rats
resolves10.2147/NDT.S44282
Mitochondrial dysfunction, oxidative stress, and major depressive disorder
resolves10.1038/mp.2012.167
Pathological parainflammation and endoplasmic reticulum stress in depression: potential translational targets through the CNS insulin, klotho and PPAR-γ systems
resolves10.1016/j.biopsych.2012.12.004
Social Isolation Exacerbates Schizophrenia-Like Phenotypes via Oxidative Stress in Cortical Interneurons
resolves10.3389/fncir.2012.00044
The origin of neocortical nitric oxide synthase-expressing inhibitory neurons
resolves10.1016/j.biopsych.2009.04.033
Involvement of NOX2 in the Development of Behavioral and Pathologic Alterations in Isolated Rats
resolves10.1038/npp.2010.31
Stress Impairs GABAergic Network Function in the Hippocampus by Activating Nongenomic Glucocorticoid Receptors and Affecting the Integrity of the Parvalbumin-Expressing Neuronal Network
resolves10.1016/j.neuropharm.2011.01.049
Behavioral and neurochemical consequences of cortical oxidative stress on parvalbumin-interneuron maturation in rodent models of schizophrenia
resolves10.1016/j.nbd.2011.01.014
Reduced somatostatin in subgenual anterior cingulate cortex in major depression
resolves10.1016/0022-3956(88)90030-1
Neuropeptide Y and peptide YY as possible cerebrospinal fluid markers for major depression and schizophrenia, respectively
resolves10.1038/sj.mp.4002097
Repeated social defeat-induced depression-like behavioral and biological alterations in rats: involvement of cholecystokinin
resolves10.1016/j.neuroscience.2008.09.037
Anxiolytic and antidepressant effects of intracerebroventricularly administered somatostatin: Behavioral and neurophysiological evidence
resolves10.1016/j.peptides.2012.02.020
Neuropeptide Y: Identification of a novel rat mRNA splice-variant that is downregulated in the hippocampus and the prefrontal cortex of a depression-like model
resolves10.1016/0306-4530(84)90003-9
Low levels of somatostatin in human CSF mark depressive episodes
resolves10.1016/S0022-3956(03)00101-8
Decreased cerebrospinal fluid neuropeptide Y (NPY) in patients with treatment refractory unipolar major depression: preliminary evidence for association with preproNPY gene polymorphism
resolves10.1038/npp.2014.76
Opposing Effects of Acute versus Chronic Blockade of Frontal Cortex Somatostatin-Positive Inhibitory Neurons on Behavioral Emotionality in Mice
resolves10.1007/s00213-009-1605-5
Anxiolytic and antidepressant actions of somatostatin: the role of sst2 and sst3 receptors
resolves10.1007/s00213-011-2248-x
Anxiolytic-like effects of somatostatin isoforms SST 14 and SST 28 in two animal models (Rattus norvegicus) after intra-amygdalar and intra-septal microinfusions
resolves10.1038/npp.2016.281
Roles of Hippocampal Somatostatin Receptor Subtypes in Stress Response and Emotionality
resolves10.1016/0893-133X(87)90013-3
Cerebrospinal fluid neuropeptide Y in depression and schizophrenia
resolves10.1046/j.1471-4159.1995.65041646.x
Neuropeptide Y in Frontal Cortex Is Not Altered in Major Depression
resolves10.1016/S0304-3940(99)00234-7
Alterations in neuropeptide Y levels and Y1 binding sites in the Flinders Sensitive Line rats, a genetic animal model of depression
resolves10.1016/S0006-8993(97)00308-9
Decreased experimental anxiety and voluntary ethanol consumption in rats following central but not basolateral amygdala lesions
resolves10.1016/j.peptides.2009.12.015
Behavioral effects of neuropeptides in rodent models of depression and anxiety
resolves10.1016/S0014-2999(99)00800-6
Neuropeptide-Y exerts antidepressant-like effects in the forced swim test in rats
resolves10.1523/JNEUROSCI.21-01-00262.2001
Enhanced Cortical Extracellular Levels of Cholecystokinin-Like Material in a Model of Anticipation of Social Defeat in the Rat
resolves10.1007/s00213-011-2600-1
Lateralized hippocampal effects of vasoactive intestinal peptide on learning and memory in rats in a model of depression
resolves10.3389/fphar.2016.00446
Sex-Dependent Anti-Stress Effect of an α5 Subunit Containing GABAA Receptor Positive Allosteric Modulator
resolves10.1038/mp.2016.188
Disinhibition of somatostatin-positive GABAergic interneurons results in an anxiolytic and antidepressant-like brain state
resolves10.1016/j.biopsych.2016.12.002
Reduced Somatostatin Expression or Somatostatin-Positive Gamma-Aminobutyric Acid Neurons: A Shared Pathology Across Brain Disorders
The 3 references without a DOI — listed, not checked
no DOI — not checkedbibr4-2470547017720459
no DOI — not checkedbibr60-2470547017720459
no DOI — not checkedbibr100-2470547017720459
What this badge says. CiteStamped means the CHECKABLE references of this
work were clean at the dated check: each resolved to a known work in a public registry, and none
carried a retraction notice at that time. It says nothing about the quality, findings,
or importance of the work itself, and nothing about references deposited without a DOI.
checked 2026-07-23 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record
Embed this badge
Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.
<a href="https://citestamp.com/citestamped/10.1177/2470547017720459"><img src="https://citestamp.com/citestamped/10.1177/2470547017720459/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[](https://citestamp.com/citestamped/10.1177/2470547017720459)